Nexus Health, a strategic consulting and market access firm and part of The Lockwood Group, has announced the acquisition of Stratis Group, a consulting firm focused on commercialization strategy, market access, and analytics for pharmaceutical, biotechnology, and physician network clients.
The deal is aimed at strengthening Nexus Health’s ability to deliver integrated, data-driven solutions across the full product lifecycle, from early commercialization planning through launch and ongoing optimization. By combining Stratis Group’s capabilities with its existing offerings, Nexus Health is expanding its reach in patient services, health economics and outcomes research (HEOR), real-world evidence generation, adherence strategy, and field reimbursement management.
Founded in 2014, Stratis Group brings expertise in advanced analytics, customer research, and market insights. Its services include forecasting and epidemiology, patient support programs, brand analytics, market access optimization, and organizational development. These capabilities are expected to complement Nexus Health’s existing strengths in medical affairs, commercialization, oncology education, and access strategy.
The acquisition also aligns with The Lockwood Group’s broader growth strategy of expanding its commercialization and market access platform. In recent years, Nexus Health has widened its offerings to include strategic consulting, value communications, and patient access and affordability solutions, positioning itself as a more comprehensive partner for life sciences companies.
Clearsight Advisors served as the exclusive financial advisor to Stratis Group, while Pillsbury Winthrop Shaw Pittman LLP acted as legal counsel.
KEY QUOTES:
“Joining forces with Nexus Health and The Lockwood Group allows Stratis to scale market access solutions quicker than we could as a standalone organization. Our shared vision of science-driven, client-centered solutions will deliver greater strategic value to clients and help ensure better patient outcomes in an increasingly complex health care landscape.”
Casey Cormier, Principal & Co-Founder, Stratis Group; Joe Musumeci, Principal & Co-Founder, Stratis Group
“We’re thrilled to welcome Casey, Joe, and the entire Stratis team to Nexus Health. Stratis has built a reputation for deep strategic expertise and nimble execution across commercialization and market access challenges. This acquisition expands our integrated service offerings through deep quantitative analytics and strengthens our ability to partner with life sciences organizations at every stage of product development, launch, and growth.”
Andrew Gottfried, CEO, Nexus Health
“With the addition of Stratis, we are further strengthening our market access platform and expanding the strategic capabilities we can deliver to life sciences clients. Under Andrew’s leadership, Nexus Health has built strong momentum over the past year.”
Matthew Schecter, Founder & CEO, The Lockwood Group
